Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
EW Group Signs with China's Largest Healthcare, Sinopharm 2023-06-15 10:24
MindRank Announces First-in-Human Phase 1 Study of MDR-001 in China 2023-06-14 20:00
Sirnaomics to Present Latest Developments on GalAhead™ Therapeutic Platform at Upcoming Industry Conferences 2023-06-14 00:42
The 20th CACLP & 3rd CISCE Closed with Record-breaking Numbers in Nanchang 2023-06-12 18:45
Taipei Entrepreneurs Hub Focuses on the Greater Health Industries, Taipei City Government Facilitates Global Talents Matchmaking 2023-06-12 16:12
Innovent Announces Phase 1 Clinical Data of IBI322 (CD47/PD-L1 Bispecific Antibody) in the Treatment of Anti-PD-(L)1-resistant Classic Hodgkin Lymphoma Patients at the EHA 2023 Annual Meeting 2023-06-12 08:00
Treating COVID with Metformin Reduces Long COVID Rates 2023-06-09 21:00
Anti-Aging and Reproductive Medical Giants Gathered in Hong Kong Dragon's Medical Led Chinese Medical Development 2023-06-09 13:00
China Approves the World's First Vaccine against XBB Descendent Lineages of SARS-CoV-2 for Emergency Use 2023-06-09 11:59
Investor Open Day: Fosun Implements Business Streamlining and Resilience Building Strategy, Focusing on Core Businesses to Bring New Vitality 2023-06-09 11:16
Telix Opens European Radiopharmaceutical Production Facility 2023-06-08 20:00
Qilu Pharmaceutical Announces Trials in Progress Posters on QL1706 in Phase III NSCLC Clinical Research at ASCO 2023 2023-06-08 15:35
ACROBiosystems expands custom GMP-grade protein services to drive CGT development and commercialization 2023-06-07 16:05
BetaLife wins Cytiva's first BioChallenge Competition in Southeast Asia 2023-06-07 12:00
Colorcon, Inc. Invests in a New Film Coating Manufacturing Plant in Malaysia 2023-06-06 20:00
Telix to Present at Jefferies Healthcare Conference 2023-06-06 08:40
Transcenta Presents Updated Data of Osemitamab (TST001) in Combination with CAPOX as a First-Line Treatment of G/GEJ Cancer at 2023 ASCO Annual Meeting 2023-06-06 08:20
Innovent and IASO Bio Updated Efficacy and Safety Clinical Data of Equecabtagene Autoleucel (BCMA CAR-T Cell Therapy) for Multiple Myeloma at the 2023 ASCO Annual Meeting 2023-06-06 08:00
ASCO 2023: RemeGen Exhibits Promising Results of Disitamab Vedotin in Bladder Cancer 2023-06-05 21:26
RemeGen Demonstrates Profitability to Successfully Receive Approval from the Hong Kong Stock Exchange to Upgrade Stock Short Name 2023-06-05 21:17
1 30 31 32 33 34 229